We did not evaluate for any genetic polymorphisms for the presence of fatty liver such as Patatin-like phospholipase domain-containing protein 3 (PNPLA3) in our study; and found that 163 (42.4%) of patients with NAFLD didn’t have metabolic syndrome. Here, PNPLA3 is linked to metabolic syndrome.